BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 35052650)

  • 1. Cross-Talk between Amyloid, Tau Protein and Free Radicals in Post-Ischemic Brain Neurodegeneration in the Form of Alzheimer's Disease Proteinopathy.
    Pluta R; Kiś J; Januszewski S; Jabłoński M; Czuczwar SJ
    Antioxidants (Basel); 2022 Jan; 11(1):. PubMed ID: 35052650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apitherapy in Post-Ischemic Brain Neurodegeneration of Alzheimer's Disease Proteinopathy: Focus on Honey and Its Flavonoids and Phenolic Acids.
    Pluta R; Miziak B; Czuczwar SJ
    Molecules; 2023 Jul; 28(15):. PubMed ID: 37570596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic and Genomic Changes in Tau Protein, Which Are Associated with Alzheimer's Disease after Ischemia-Reperfusion Brain Injury.
    Ułamek-Kozioł M; Czuczwar SJ; Januszewski S; Pluta R
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-Ischemic Neurodegeneration of the Hippocampus Resembling Alzheimer's Disease Proteinopathy.
    Pluta R; Januszewski S; Czuczwar SJ
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-Ischemic Brain Neurodegeneration in the Form of Alzheimer's Disease Proteinopathy: Possible Therapeutic Role of Curcumin.
    Pluta R; Furmaga-Jabłońska W; Januszewski S; Czuczwar SJ
    Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Many Faces of Post-Ischemic Tau Protein in Brain Neurodegeneration of the Alzheimer's Disease Type.
    Pluta R; Czuczwar SJ; Januszewski S; Jabłoński M
    Cells; 2021 Aug; 10(9):. PubMed ID: 34571862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-Ischemic Permeability of the Blood-Brain Barrier to Amyloid and Platelets as a Factor in the Maturation of Alzheimer's Disease-Type Brain Neurodegeneration.
    Pluta R; Miziak B; Czuczwar SJ
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Participation of Amyloid and Tau Protein in Post-Ischemic Neurodegeneration of the Hippocampus of a Nature Identical to Alzheimer's Disease.
    Pluta R; Ouyang L; Januszewski S; Li Y; Czuczwar SJ
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linking Oxidative Stress and Proteinopathy in Alzheimer's Disease.
    Sharma C; Kim SR
    Antioxidants (Basel); 2021 Jul; 10(8):. PubMed ID: 34439479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Participation of Amyloid and Tau Protein in Neuronal Death and Neurodegeneration after Brain Ischemia.
    Pluta R; Ułamek-Kozioł M; Januszewski S; Czuczwar SJ
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32605320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.
    Perez-Nievas BG; Stein TD; Tai HC; Dols-Icardo O; Scotton TC; Barroeta-Espar I; Fernandez-Carballo L; de Munain EL; Perez J; Marquie M; Serrano-Pozo A; Frosch MP; Lowe V; Parisi JE; Petersen RC; Ikonomovic MD; López OL; Klunk W; Hyman BT; Gómez-Isla T
    Brain; 2013 Aug; 136(Pt 8):2510-26. PubMed ID: 23824488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain Ischemia as a Prelude to Alzheimer's Disease.
    Pluta R; Januszewski S; Czuczwar SJ
    Front Aging Neurosci; 2021; 13():636653. PubMed ID: 33679381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Hydrogen Neuroprotection in Post-Ischemic Neurodegeneration in the Form of Alzheimer's Disease Proteinopathy: Underlying Mechanisms and Potential for Clinical Implementation-Fantasy or Reality?
    Pluta R; Januszewski S; Czuczwar SJ
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Dual Role of Autophagy in Postischemic Brain Neurodegeneration of Alzheimer's Disease Proteinopathy.
    Pluta R
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular bases of Alzheimer's disease and other neurodegenerative disorders.
    Maccioni RB; Muñoz JP; Barbeito L
    Arch Med Res; 2001; 32(5):367-81. PubMed ID: 11578751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigations on oxidative stress and therapeutical implications in dementia.
    Durany N; Münch G; Michel T; Riederer P
    Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 3():68-73. PubMed ID: 10654103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of mitochondrial dysfunction, oxidative stress and autophagy in progression of Alzheimer's disease.
    Bhatia V; Sharma S
    J Neurol Sci; 2021 Feb; 421():117253. PubMed ID: 33476985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress and DNA damage after cerebral ischemia: Potential therapeutic targets to repair the genome and improve stroke recovery.
    Li P; Stetler RA; Leak RK; Shi Y; Li Y; Yu W; Bennett MVL; Chen J
    Neuropharmacology; 2018 May; 134(Pt B):208-217. PubMed ID: 29128308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of oxidative stress in Alzheimer's disease.
    Huang WJ; Zhang X; Chen WW
    Biomed Rep; 2016 May; 4(5):519-522. PubMed ID: 27123241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sporadic Alzheimer's disease begins as episodes of brain ischemia and ischemically dysregulated Alzheimer's disease genes.
    Pluta R; Jabłoński M; Ułamek-Kozioł M; Kocki J; Brzozowska J; Januszewski S; Furmaga-Jabłońska W; Bogucka-Kocka A; Maciejewski R; Czuczwar SJ
    Mol Neurobiol; 2013 Dec; 48(3):500-15. PubMed ID: 23519520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.